Physician

Emily Dell, M.D.

According to 2025 Medicare claims, Emily Dell, M.D. (NPI: 1538575709) practices dermatology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is TRICITIES SKIN AND CANCER (NPI: 1295824415; TIN: 621822644) and primary practice location at 37604-3693.

Dell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 889 traditional Medicare patients, billed 9,209 HCPCS/CPT codes, and received $208,998 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,047 prescription claims across 451 beneficiaries totaling $501,100 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 31 records totaling $633. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,475 to $208,998. Similarly, Part D prescription costs have risen steadily, from $2,641 to $501,100. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$123K$245K2016 Medicare payment: $8,475 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $45,144 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $84,412 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $245,342 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $219,126 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $216,549 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $212,117 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $230,905 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $208,998 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201664196$8,475
20173881,024$45,144
20185281,904$84,412
20191,05212,534$245,342
202094310,850$219,126
20218949,948$216,549
202295610,020$212,117
202399010,497$230,905
20248899,209$208,998

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$251K$501K2015 Drug cost: $2,641 (USD; Tot_Drug_Cst)2016 Drug cost: $6,887 (USD; Tot_Drug_Cst)2017 Drug cost: $103,008 (USD; Tot_Drug_Cst)2018 Drug cost: $158,451 (USD; Tot_Drug_Cst)2019 Drug cost: $101,039 (USD; Tot_Drug_Cst)2020 Drug cost: $77,810 (USD; Tot_Drug_Cst)2021 Drug cost: $131,338 (USD; Tot_Drug_Cst)2022 Drug cost: $97,504 (USD; Tot_Drug_Cst)2023 Drug cost: $173,659 (USD; Tot_Drug_Cst)2024 Drug cost: $501,100 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151728$2,641
20165498$6,887
2017173368$103,008
2018246530$158,451
2019363770$101,039
2020354833$77,810
2021352728$131,338
2022392857$97,504
2023421883$173,659
20244511,047$501,100

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths226268$73
11102Biopsy of related skin growth, first growth224253$56
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7001,010$56
17000Destruction of precancer skin growth, 1 growth432585$32
17003Destruction of precancer skin growth, 2-14 growths3382,115$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab24672$195,566
Dupixent PenDupilumab11308$40,927
Clobetasol PropionateClobetasol Propionate842,211$4,057
Clindamycin PhosphateClindamycin Phosphate381,125$1,510
KetoconazoleKetoconazole902,495$1,504

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$633Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Emily Dell, M.D.?

Tedicare shows public-source Medicare data for Emily Dell, M.D. (NPI 1538575709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Dell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Emily Dell, M.D.?

Emily Dell, M.D. is linked to TRICITIES SKIN AND CANCER (billing NPI 1295824415) in the available physician profile data.

Does Emily Dell, M.D. have Open Payments data?

Emily Dell, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.